Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
IGM to Slash 73% of Workforce, Halt Two Drug Programs
Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events
Vir Biotech Upgraded at Morgan Stanley on Cancer Drug Data
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report